ARWR
Arrowhead Pharmaceuticals Inc
65.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Arrowhead Pharmaceuticals Inc (ARWR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -177 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -118 | -92 | -115 | -137 | -146 | 460 | -155 | 20 | 13 | 84 | -177 | -59 | |
| 3.9 | 4.3 | 4.5 | 4.8 | 5.0 | 5.2 | 6.1 | 6.2 | 6.4 | 6.4 | 7.0 | 6.0 | 26 | |
| 18 | 20 | 18 | 17 | 19 | 15 | 16 | 13 | 19 | 19 | 17 | 15 | 70 | |
| 21 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 59 | -11 | 3.4 | 25 | 8.0 | -7.4 | 46 | -18 | -38 | -62 | 199 | -46 | 53 | |
| 64 | 69 | 34 | 14 | 24 | 7.5 | 5.3 | 2.4 | 7.5 | 2.1 | 2.6 | 3.9 | 16 | |
| 31 | 65 | -269 | 6.9 | -223 | 77 | -420 | 141 | 73 | -24 | -894 | 44 | -802 | |
| – | – | – | – | – | – | – | – | – | – | 42 | 38 | – | |
| – | – | – | – | – | 0.0 | -152 | -50 | 10 | -67 | 812 | -33 | 722 | |
| 0.2 | 0.3 | 431 | 50 | 389 | 21 | 92 | -43 | 3.7 | -15 | 796 | -0.4 | 784 | |
| 5.6 | -53 | 69 | -58 | 33 | -49 | 132 | -56 | 97 | -25 | -13 | -134 | -75 | |
| -89 | -186 | -126 | -130 | -162 | -154 | 455 | -157 | 13 | 11 | 82 | -181 | -75 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.